The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors
Open accessAbstract
BACKGROUND: Randomized trials have shown that the transplantation of filgrastim-mobilized peripheral-blood stem cells from HLA-identical siblings accelerates engraftment but increases the risks of acute and chronic graft-versus-host disease (GVHD), as compared with the transplantation of bone marrow. Some studies have also shown that peripheral-blood stem cells are associated with a decreased rate of relapse and improved survival among recipients with high-risk leukemia. METHODS: We conducted a phase 3, multicenter, randomized trial of transplantation of peripheral-blood stem cells versus bone marrow from unrelated donors to compare 2-year survival probabilities with the use of an intention-to-treat analysis. Between March 2004 and September 2009, we enrolled 551 patients at 48 centers. Patients were randomly assigned in a 1:1 ratio to peripheral-blood stem-cell or bone marrow transplantation, stratified according to transplantation center and disease risk. The median follow-up of surviving patients was 36 months (interquartile range, 30 to 37). RESULTS: The overall survival rate at 2 years in the peripheral-blood group was 51% (95% confidence interval [CI], 45 to 57), as compared with 46% (95% CI, 40 to 52) in the bone marrow group (P=0.29), with an absolute difference of 5 percentage points (95% CI, -3 to 14). The overall incidence of graft failure in the peripheral-blood group was 3% (95% CI, 1 to 5), versus 9% (95% CI, 6 to 13) in the bone marrow group (P=0.002). The incidence of chronic GVHD at 2 years in the peripheral-blood group was 53% (95% CI, 45 to 61), as compared with 41% (95% CI, 34 to 48) in the bone marrow group (P=0.01). There were no significant between-group differences in the incidence of acute GVHD or relapse. CONCLUSIONS: We did not detect significant survival differences between peripheral-blood stem-cell and bone marrow transplantation from unrelated donors. Exploratory analyses of secondary end points indicated that peripheral-blood stem cells may reduce the risk of graft failure, whereas bone marrow may reduce the risk of chronic GVHD. (Funded by the National Heart, Lung, and Blood Institute-National Cancer Institute and others; ClinicalTrials.gov number, NCT00075816.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jagasia, M. H., Greinix, H. T., Arora, M., Williams, K. M., Wolff, D., Cowen, E. W., Palmer, J., Weisdorf, D., Treister, N. S., Cheng, G.-S., et al. (2015) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2014.12.001 · Cited by 5,459
Self-citationFilipovich, A. H., Weisdorf, D., Pavletic, S., Socie, G., Wingard, J. R., Lee, S. J., Martin, P., Chien, J., Przepiorka, D., Couriel, D., et al. (2005) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2005.09.004 · Cited by 3,556
Self-citationChronic graft-versus-host syndrome in man
Shulman, H. M., Sullivan, K. M., Weiden, P. L., McDonald, G. B., Striker, G. E., Sale, G. E., Hackman, R., Tsoi, M.-S., Storb, R., & Donnall Thomas, E. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90380-0 · Cited by 2,406
Lee, S. J., Klein, J., Haagenson, M., Baxter-Lowe, L. A., Confer, D. L., Eapen, M., Fernandez-Vina, M., Flomenberg, N., Horowitz, M., Hurley, C. K., et al. (2007) · Blood · doi:10.1182/blood-2007-06-097386 · Cited by 1,255
Self-citationBensinger, W. I., Martin, P. J., Storer, B., Clift, R., Forman, S. J., Negrin, R., Kashyap, A., Flowers, M. E. D., Lilleby, K., Chauncey, T. R., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101183440303 · Cited by 962
Self-citationFinke, J., Bethge, W. A., Schmoor, C., Ottinger, H. D., Stelljes, M., Zander, A. R., Volin, L., Ruutu, T., Heim, D. A., Schwerdtfeger, R., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70225-6 · Cited by 727
Schmitz, N., Dreger, P., Suttorp, M., Rohwedder, E., Haferlach, T., Löffler, H., Hunter, A., & Russell, N. H. (1995) · Blood · doi:10.1182/blood.v85.6.1666.bloodjournal8561666 · Cited by 503
(2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.020 · Cited by 451
NON-PARAMETRIC INFERENCE FOR CUMULATIVE INCIDENCE FUNCTIONS IN COMPETING RISKS STUDIES
LIN, D. Y. (1997) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19970430)16:8<901::aid-sim543>3.0.co;2-m · Cited by 445
Flowers, M. E. D., Parker, P. M., Johnston, L. J., Matos, A. V. B., Storer, B., Bensinger, W. I., Storb, R., Appelbaum, F. R., Forman, S. J., Blume, K. G., et al. (2002) · Blood · doi:10.1182/blood-2002-01-0011 · Cited by 421
Self-citationSierra, J., Storer, B., Hansen, J. A., Bjerke, J. W., Martin, P. J., Petersdorf, E. W., Appelbaum, F. R., Bryant, E., Chauncey, T. R., Sale, G., et al. (1997) · Blood · doi:10.1182/blood.v89.11.4226 · Cited by 373
Self-citationPowles, R., Mehta, J., Kulkarni, S., Treleaven, J., Millar, B., Marsden, J., Shepherd, V., Rowland, A., Sirohi, B., Tait, D., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02090-0 · Cited by 354
Couban, S. (2002) · Blood · doi:10.1182/blood-2002-01-0048 · Cited by 336
Self-citationMajor-Histocompatibility-Complex Class I Alleles and Antigens in Hematopoietic-Cell Transplantation
Petersdorf, E. W., Hansen, J. A., Martin, P. J., Woolfrey, A., Malkki, M., Gooley, T., Storer, B., Mickelson, E., Smith, A., & Anasetti, C. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011826 · Cited by 335
Self-citationSchmitz, N. (2002) · Blood · doi:10.1182/blood-2001-12-0304 · Cited by 271
Pasquini, M. C., Wang, Z. P., Horowitz, M. M., & Gale, R. P. (2013) · PubMed · Cited by 220
Self-citationMorton, J., Hutchins, C., & Durrant, S. (2001) · Blood · doi:10.1182/blood.v98.12.3186 · Cited by 181
Guardiola, P. (2002) · Blood · doi:10.1182/blood.v99.12.4370 · Cited by 142
Friedrichs, B., Tichelli, A., Bacigalupo, A. P., Russell, N. H., Ruutu, T., Shapira, M. Y., Beksaç, M., Hasenclever, D., Socié, G., & Schmitz, N. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70352-3 · Cited by 136
Pasquini, M. C., Wang, Z. P., Horowitz, M. M., & Gale, R. P. (2010) · PubMed · Cited by 117
Self-citation
Cited by
Döhner, H., Weisdorf, D. J., & Bloomfield, C. D. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1406184 · Cited by 3,306
Self-citationValidation and refinement of the Disease Risk Index for allogeneic stem cell transplantation
Armand, P., Kim, H. T., Logan, B. R., Wang, Z., Alyea, E. P., Kalaycio, M. E., Maziarz, R. T., Antin, J. H., Soiffer, R. J., Weisdorf, D. J., et al. (2014) · Blood · doi:10.1182/blood-2014-01-552984 · Cited by 949
Self-citationMalcovati, L., Hellström-Lindberg, E., Bowen, D., Adès, L., Cermak, J., del Cañizo, C., Della Porta, M. G., Fenaux, P., Gattermann, N., Germing, U., et al. (2013) · Blood · doi:10.1182/blood-2013-03-492884 · Cited by 669
Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease
Kröger, N., Solano, C., Wolschke, C., Bandini, G., Patriarca, F., Pini, M., Nagler, A., Selleri, C., Risitano, A., Messina, G., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1506002 · Cited by 573
Holtan, S. G., DeFor, T. E., Lazaryan, A., Bejanyan, N., Arora, M., Brunstein, C. G., Blazar, B. R., MacMillan, M. L., & Weisdorf, D. J. (2015) · Blood · doi:10.1182/blood-2014-10-609032 · Cited by 500
Self-citation
Metadata
- Authors
- Anasetti, C., Logan, B. R., Lee, S. J., Waller, E. K., Weisdorf, D. J., Wingard, J. R., Cutler, C. S., Westervelt, P., Woolfrey, A., Couban, S., Ehninger, G., Johnston, L., Maziarz, R. T., Pulsipher, M. A., Porter, D. L., Mineishi, S., McCarty, J. M., Khan, S. P., Anderlini, P., Bensinger, W. I., Leitman, S. F., Rowley, S. D., Bredeson, C., Carter, S. L., Horowitz, M. M., & Confer, D. L.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-10-18
- Volume
- 367
- Issue
- 16
- Pages
- 1487-1496
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2126021331
- Cited by
- 920
- References
- 20
- FWCI
- 35.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.